Medtronic, a US medical device company, formed a partnership with Chengdu’s municipal government to manufacture advanced diabetes devices in Chengdu. Medtronic agreed to invest in a facility that will manufacture a next-generation sensor augmented pump system for insulin delivery. Medtronic will also partner with Chengdu’s government to enable diabetic citizens of Sichuan province to access this up-to-date technology, which includes software displayed in Chinese.
